Login / Signup

Rapid HER2 cytologic fluorescence in situ hybridization for breast cancer using noncontact alternating current electric field mixing.

Shin-Nosuke WatanabeKazuhiro ImaiHiroshi NanjoYuki WakamatsuYoshihiko KimuraYoshihisa KatayoseShuichi KamataKaori TerataEriko TakahashiAyano IbonaiAyuko YamaguchiHikari KonnoMisako YatsuyanagiChiaki KudoShinogu TakashimaYoichi AkagamiRyuta NakamuraYusuke SatoSatoru MotoyamaKyoko NomuraYoshihiro Minamiya
Published in: Cancer medicine (2020)
CytoFISH could potentially serve as a clinical tool for prompt determination of HER2 status in breast cancer cytology. Rapid-CytoFISH with AC mixing will enable cancer diagnoses and HER2 status to be determined on the same day a patient comes to a clinic or hospital.
Keyphrases